Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Short-term Investments (2018 - 2025)

Dna X filings provide 7 years of Short-term Investments readings, the most recent being $2.2 million for Q3 2025.

  • On a quarterly basis, Short-term Investments changed N/A to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.2 million, a N/A change, with the full-year FY2024 number at $2.7 million, up 1269.04% from a year prior.
  • Short-term Investments hit $2.2 million in Q3 2025 for Dna X, down from $3.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $3.4 million in Q2 2025 to a low of $197000.0 in Q4 2023.
  • Median Short-term Investments over the past 4 years was $2.4 million (2024), compared with a mean of $2.1 million.
  • Biggest five-year swings in Short-term Investments: fell 8.12% in 2021 and later surged 1269.04% in 2024.
  • Dna X's Short-term Investments stood at $1.0 million in 2021, then crashed by 81.08% to $197000.0 in 2023, then surged by 1269.04% to $2.7 million in 2024, then fell by 18.95% to $2.2 million in 2025.
  • The last three reported values for Short-term Investments were $2.2 million (Q3 2025), $3.4 million (Q2 2025), and $2.8 million (Q1 2025) per Business Quant data.